Dean\u27s Research Newsletter, May 2021 by Nadler, Jerry L
Touro Scholar 
SOM Dean's Research Newsletter NYMC Publications 
5-2021 
Dean's Research Newsletter, May 2021 
Jerry L. Nadler 
New York Medical College 
Follow this and additional works at: https://touroscholar.touro.edu/nymc_som_research_newsletter 
 Part of the Medical Education Commons, and the Medical Sciences Commons 
Recommended Citation 
Nadler, J. L. (2021). Dean's Research Newsletter, May 2021. Retrieved from 
https://touroscholar.touro.edu/nymc_som_research_newsletter/14 
This Short Communication is brought to you for free and open access by the NYMC Publications at Touro Scholar. 
It has been accepted for inclusion in SOM Dean's Research Newsletter by an authorized administrator of Touro 
Scholar. For more information, please contact Timothy J Valente touro.scholar@touro.edu. 
DEAN’S RESEARCH NEWSLETTER                                   May 2021
AOA Grant Received to Support 
Educational Leadership Program to 
Combat Systemic Racism and Implicit Bias
Redab Alnifaidy, SOM Class of 2023
Lior Levy, SOM Class of 2023
Mill Etienne, M.D. ’02, M.P.H., 
vice chancellor for diversity and inclusion and 
SOM associate dean of student affairs
Pamela Ludmer, M.D., M.M.E.L., 
SOM associate dean for curriculum integration
Jerry L. Nadler, M.D., MACP, FAHA, FACE
Dean of the School of Medicine    
Professor of Medicine and Pharmacology
Dear Members of the New York Medical College (NYMC) Community,
I am excited to share with you the May edition of the research newsletter that spotlights recent 
research news from across NYMC School of Medicine (SOM) both in the clinical and basic 
science areas. 
It is particularly gratifying to see the commitment to research among our faculty, residents and 
students during this very difficult year. While this newsletter reports on a number of research 
projects, it represents just a small sample of the important work being conducted here at NYMC 
and across our wide network of clinical affiliates to advance us scientifically. 
We remain committed to supporting research as a major mission, through the faculty research 
incentive program, purchases of new equipment and by partnering with the Touro’s Bridge and 
Seed Funding Grant program, which our faculty are eligible to receive. 
Congratulations on your research accomplishments and success in securing grants. It is clear that important research progress 
positively impacts all of us as reflected by the advances in addressing the COVID-19 pandemic. Much more progress lies ahead. 
Be safe and well.
NIH Funds Research to Help Understand Link between Diabetes and Alzheimer’s 
Disease
Alzheimer’s disease leads to progressive loss of brain function and there 
is currently no effective treatment. Patients with diabetes have a higher 
risk for developing Alzheimer’s disease. Researchers at NYMC and 
Eastern Virginia Medical School (EVMS) are collaborating to study the link 
between obesity, diabetes, heart disease and brain dysfunction that could 
lead to earlier interventions and new treatment options for Alzheimer’s 
disease. The new study, “Impact of Atherosclerosis, Metabolic Syndrome 
and STAT4-dependent Immunity on Alzheimer’s Disease,” is supported by 
a grant of $402,764 from the National Institutes of Health.
“Alzheimer’s disease is a chronic progressive neurodegenerative disease 
and the most common form of dementia in the elderly, effecting 5.8 million 
Americans in 2020,” said Jerry L. Nadler, M.D., SOM dean and professor 
of medicine and of pharmacology at NYMC. “None of the pharmacologic treatments available today for Alzheimer’s slow or stop 
the damage and destruction of neurons that cause the disease and make the disease fatal.”
Patric K. Stanton, Ph.D., professor of cell biology and anatomy and of neurology at NYMC, has teamed with Dr. Nadler and 
Elena Galkina, Ph.D., professor of microbiology and molecular cell biology at EVMS, to focus on the role of signal transducer and 
activator of transcription 4 (STAT4)—a protein that attaches to specific regions of DNA to help control activity of certain genes—as 
it relates to possible immune cell function. Changing activity or expression of STAT4 could lead to new treatments for diabetes and 
heart disease. 
“We have demonstrated in our research that global deletion of STAT4 prevents diet-induced fat tissue inflammation and 
atherosclerosis,” said Dr. Nadler. 
This new research extends their study of STAT-4’s role in diabetes and heart disease to investigate the potential role of STAT4-
dependent immunity in prevention of Alzheimer disease. Read full story on new research into Alzheimer’s disease. 
Research by NYMC Faculty and Students Finds Longer Window for Successful 
Testicular Salvage Following Testicular Torsion 
Testicular torsion is one of the most common pediatric urologic emergencies, accounting for 10 to 
15 percent of acute scrotal disease in males under the age of 18 years. Traditionally, surgeons have 
used a six-hour window to determine whether a testicle can be successfully salvaged. However, new 
research by NYMC students and faculty has found that the time window may be much longer for 
surgical testicular salvage (orchidopexy). 
“Current literature regarding testicular torsion continues to reference a six-hour ‘golden rule’ of 
symptom duration for testicular salvage,” said Yuval Elkun, (right) SOM Class of 2022 and lead 
author on the research study. “Patients presenting to the emergency department (ED) within the 
six-hour window have a high chance of orchidopexy while patients 
presenting after the six-hour window likely have a necrotic testicle 
requiring removal (i.e. orchiectomy). However, our study found that the window of opportunity for a 
testicular salvage rate of more than 90 percent following testicular torsion extends far beyond the 
currently accepted six hours—even up to 24 hours.”
Additional authors on the study include Henry Dumke, (left) SOM Class of 2022; Jason Elyaguov, 
M.D., urology resident; Miriam Harel, M.D., clinical assistant professor of urology; Lori Dyer, M.D., 
assistant professor of urology; Richard Schlussel, M.D., clinical assistant professor of urology; 
Paul Zelkovic, M.D., clinical assistant professor of urology; and John Phillips, M.D., professor of 
urology. Read full story on research into testicular torsion. 
Yuval Elkun
Henry Dumke
NYMC Resident Receives Top Research Award at American Urological 
Association Meeting
Jason Elyaguov, M.D., (bottom right of the screen) urology 
resident at Westchester Medical Center, received the top award in 
translational research at the annual Ferdinand C. Valentine Resident 
Essay Meeting of the New York Section of the American Urological 
Association on April 11 for his research into the effects of two natural 
extracts on bladder cancer prevention. 
“Bladder cancer is a highly prevalent disease, being the fifth most 
commonly treated cancer, and projected to affect 84,000 people 
in 2021,” said Dr. Elyaguov. “Yet limited therapies for this disease 
often lead to multiple recurrences and even worse progression. 
Consequently, there is an urgent need for a more effective, readily available and safer treatment modality.”
Phellinus linteus, a medicinal mushroom grown on mulberry trees, has been used in East Asia for several ailments but also 
has demonstrated anti-tumorigenic activity in both in vitro and in vivo studies for several cancers. Proanthocyanidin, a natural 
bioflavonoid found in grapeseed, similarly demonstrates several anti-tumorigenic properties with a possible chemo-sensitizing 
effect and no reported side effects.
For the study, Dr. Elyaguov, under the mentorship of Sensuke Sato, Ph.D. ’92, associate professor of urology, theorized that 
given the individual anti-cancer activities of the extracts the combination of the two extracts might further potentiate such 
activity against bladder cancer.  
“Ultimately, we found that both mushroom and grapeseed extracts showed a significant reduction in bladder cancer cell 
viability,” he said. “Moreover, their combination consistently demonstrated a synergistic cell viability reduction, as much as 
85 percent, by way of oxidative stress and programmed cell death (apoptosis). This study thus highlights two natural, readily 
available products that may serve as effective and safe intravesical therapies in the fight against bladder cancer.”
Bridge and Seed Funding Grants Awarded to NYMC Faculty
NYMC researchers have been awarded bridge and seed funding grants from Touro College and University System (TCUS). 
Bridge grants sustain research projects between large grant funding and seed grants enable research to gather initial data. 
“The outcomes of our faculty’s research and scholarship feature prominently in our reputation as an institution of higher 
education,” said Salomon Amar, D.D.S., Ph.D., vice president for research at NYMC and senior vice president for research 
affairs for TCUS and chair of the TCUS Biomedical and Health Sciences Research Council. “The bridge and seed funding 
grant programs are one of several initiatives both system-centric and campus-centric by which we seek to recognize 
excellence and support research as a fundamental component of Touro’s mission.”
Wen-Hui Wang, M.D., professor of pharmacology, was awarded a bridge funding grant that will allow him to complete several 
key experiments as he prepares to resubmit his NIH-funded, multi-year RO1 grant on “The Role of Kir4.1 in Regulating NCC 
and ROMK in DCT.”
“The proposed grant application will test a novel mechanism by which the kidney can sense the change in dietary potassium 
content and regulate potassium excretion or absorption,” said Dr. Wang. “The new concept will expend the current knowledge 
regarding renal potassium transport and may lead to development of new approach for the treatment of abnormal high plasma 
potassium concentrations, known as hyperkalemia, a potentially fatal disorder that can cause irregular heartbeat (arrhythmia).”
Sharath Kandhi, M.D., Ph.D., instructor of physiology, who is working with Zvi Loewy, Ph.D., professor and associate dean 
for research at Touro College of Pharmacy, received a seed funding grant for the project, “Clinical Trial Readiness of Small 
Molecular Therapeutics Against Pulmonary Hypertension-SMURF1 Ubiquitin Ligase as Target.”
“Pulmonary hypertension is a serious disease characterized by thickening of the blood vessel wall resulting in elevated 
blood pressure in the lungs leading to progressive right heart failure and premature death,” said Dr. Kandhi. “With no cure 
for pulmonary hypertension, our grant proposal addresses underlying causes of the blood vessel wall changes seen in this 
disease to find new options for preventing and treating pulmonary hypertension.” 
“As an early career investigator with vast experience in PH and cardiovascular research, I am grateful for this seed funding 
which will support integrated research and resources to allow us to compete for independent extramural grant support. I am 
deeply grateful to the NYMC and Touro leadership for their faith and trust in us and the encouragement to stimulate basic 
discoveries that have great potential to be translated into clinical practice.”
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Grants Corner
Chandra Shekhar Bakshi, D.V.M., Ph.D., assistant professor of neurosurgery, received a $94,669 grant from the National 
Institutes of Health (NIH) for “Characterization of Francisella tularensis-specific bacteriophages.” 
Sangmi Chung, Ph.D., associate professor of cell biology and anatomy, neurology and of psychiatry and behavioral 
sciences, received a $565,775 grant from the NIH for “Stem Cell-derived Developmental Human Cortical Interneurons to Treat 
Intractable Epilepsy.”   
Thomas Diflo, M.D., professor of surgery, received a $166,455 grant from CareDx for “Evaluation of Patient Outcomes from 
the Kidney Allograft Outcomes AlloSure Registry (KOAR)” and a $215,498 grant from Natera for “The PROspera Kidney 
Transplant ACTIVE Rejection Assessment registry (ProActive) study.”    
Masashi Kai, M.D., assistant professor of surgery, received a $79,655 grant from TransMedics for “The Portable Organ 
Care System (OCS™) Heart for Resuscitation, Preservation and Assessment of Hearts from Donors after Circulatory Death 
Continued Access Protocol (OCS DCD Heart CAP).”    
David F. Kronn, M.D., associate professor of pediatrics and of pathology, microbiology and immunology, received a $39,000 
grant from Sanofi US Services for “A prospective and retrospective cohort study to refine and expand the knowledge on 
patients with chronic forms of Acid Sphingomyelinase Deficiency (ASMD).”                                                                                 
Edmund F. LaGamma, M.D. ’76, professor of pediatrics and of biochemistry and molecular biology, received a $6,300 grant 
from the University of Pittsburgh for “The NICU Antibiotics and Outcomes (NANO) Trial.”                                                         
Igor Laskowski, M.D., Ph.D., associate professor of surgery, received a $17,550 grant from the New England Research 
Institute for “The Therapeutic Strategies, Outcomes and Costs of Critical Limb Ischemia in BEST-CLI Study.”
Rifat Latifi, M.D., professor and chair of Department of Surgery, received a $214,594 grant from Allergan for “Long term 
patient reported outcomes following Complex abdominal wall reconstruction with Strattice. A prospective observational study”
Alison T. Lennox, M.D., clinical assistant professor of medicine and pediatrics, received a $60,878 grant from the Cystic 
Fibrosis Foundation via Seattle Children’s Hospital for “A Master Protocol to Test the Impact of Discontinuing Chronic 
Therapies in People with Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY).”
Christopher Leonard, Ph.D., professor and interim chair of Department of Physiology, received $136,377 grant from 
University of California Los Angeles for “Role of Hypocretin in Opiate Addiction and Withdrawal.”
Xiu-Min Li, M.D., professor of pathology, microbiology and immunology, received a $50,000 grant form miscellaneous donors 
for “Study of the Effect of BRF Natural Compound on Multiple Myeloma Cells.”                                              
Delong Liu, M.D., Ph.D., professor of medicine, received a $55,490 grant from Acerta for “An Open-label, Phase 1b/2 Study 
of Acalabrutinib Alone or in Combination Therapy in Subjects with B-cell Non-Hodgkin Lymphoma” and a $123,984 grant 
from Syneos for “A Phase 4, Open-Label, Random Study of Two Inotuzumab Ozogamicin Dose Levels in Adult Patients with 
Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Eligible for Hematopoietic Stem Cell Trans and Who Have Risk 
Factor(s) for Veno-Occlusive Disease.”
Jerry L. Nadler, M.D., SOM dean and professor of medicine and pharmacology, received a $162,088 grant from the NIH 
National Institute of Diabetes and Digestive and Kidney Diseases for “Role of 12-lipoxygenase and 12-HETE signaling in 
beta-cell dysfunction,” as well as a $154,320 grant for “Myeloid cell-specific role of STAT4 in atherosclerosis and metabolic 
dysfunction” and a $202,764 grant for “Impact of Atherosclerosis, Metabolic Syndrome, and STAT4-dependent Immunity on 
Alzheimer’s Disease” from the NIH National Heart, Lung and Blood Institute with subcontract from Eastern Virginia Medical 
School.
Lance A. Parton, M.D. ’80, professor of pediatrics, received a $19,644 grant from Regeneron for “A Randomized, 
Controlled, Multi-Center Study to Assess the Efficacy, Safety and Tolerability of Intravitreal Aflibercept Compared to Laser 
Photocoagulation in Patients with Retinopathy of Prematurity” and a $25,264 grant from Chiesi Pharmaceutical for “Phase 
II, multicenter, double blind, double dummy, randomized, two-arm parallel study to evaluate the efficacy, safety and 
pharmacokinetics of CHF6563 in babies with Neonatal Opioid Withdrawal Syndrome.”                                                                       
Patric K. Stanton, Ph.D., professor of cell biology and anatomy and of neurology, received a $156,000 grant from Gate 
Neuroscience for “NMDA Receptor Modulators as Neurotherapeutics.”   
Katrina R. Stidham, M.D., assistant professor of clinical otolaryngology and neurosurgery, received a $18,000 grant from 
Cochlear for “Outcomes of group Aural Rehabilitation for older adult cochlear implant recipients.”                                         
Libor Velišek, M.D., Ph.D., professor of cell biology and anatomy, pediatrics and of neurology, received a $451,000 grant from 
the NIH for “Systematic Search for Novel Treatments of Infantile Spasms among Sigma-1 Receptor Ligands.”     
John Welter, M.D., assistant professor of pediatrics, received a $117,141 grant from the Cystic Fibrosis Foundation via 
Seattle Children’s Hospital for “A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR 
Function in Infants and Young Children (BEGIN).”           
Pediatric and Adult Epilepsy Research Program Formed
Epilepsy—in which brain activity becomes abnormal, causing seizures or periods 
of unusual behavior sensations, and sometimes loss of awareness—afflicts 
approximately 3.5 million people in the United States, including 500,000 children, 
making it one of the most common neurological disorders. NYMC, Westchester 
Medical Center (WMC) and Boston Children’s Health Physicians (BCHP) have 
collaborated to create a research program in pediatric and adult epilepsy, which 
brings clinicians and basic science researchers together to work to develop new, 
more effective epilepsy treatments. 
“The new age of rapid drug development, new devices and genetic research in the 
field of epilepsy is very promising,” says Leonard Newman, M.D. ’70, professor and 
chair of the Department of Pediatrics at NYMC and president of BCHP. “We are very excited to introduce this new research 
program and look forward to more opportunities for transitional bench to clinical research in the field of epilepsy as a result.”
Last year, Steven Wolf, M.D., FAES, and Patricia McGoldrick, M.P.A., M.S.N., N.P., FAES, who have a wealth of clinical and 
research experience in epilepsy, were recruited from Mount Sinai to join the NYMC neurological research team, which includes 
Libor Velišek, M.D., Ph.D., FAES, professor of cell biology and anatomy, pediatrics and of neurology, and assistant dean 
for basic medical sciences, who has been principal investigator on numerous NIH-funded grants on translational research in 
developmental epilepsy and published more than 180 primary papers and book chapters on the subject; Jana Veliskova, M.D., 
Ph.D., professor of cell biology and anatomy, obstetrics and gynecology and of neurology, who has published on adult-age 
epilepsies and female epilepsy issues; Patric K. Stanton, Ph.D., professor of cell biology and anatomy and of neurology, who 
has published on plasticity in epilepsy, and Eliana Scemes, Ph.D., professor of cell biology and anatomy, who has published 
on glial contribution in epilepsy.
Several studies into innovative treatments are currently underway, including a clinical trial to assess the long-term safety of 
the oral solution fenfluramine hydrochloride as an adjunctive therapy for seizures in patients with rare seizure disorders, such 
as epileptic encephalopathies, and a preliminary study to validate a screening tool developed for the identification of Lennox 
Gastaut syndrome in patients with intractable drug resistant epilepsy. Dr. Velisek also recently received at $451,000 grant from 
the National Institutes of Health to study a new class of compounds (sigma receptor ligands) as possible novel treatments of 
infantile spasms, a devastating epilepsy syndrome of childhood with limited treatment options that have to date shown only 
partial efficacy and serious adverse effects. Read full story on new epilepsy research program.
Abhay Dhand, M.D., Delivers Keynote Address at Touro Research Day
Over the past year, the medical community marshaled its full array of resources to combat 
COVID-19, the disease that has resulted in millions of deaths worldwide. With New York, 
and Westchester County in particular, at the epicenter of the major outbreak of COVID-19 in 
the United States last March, Abhay Dhand, M.D., associate professor of clinical medicine 
at NYMC and director of transplant infectious diseases and the Antimicrobial Stewardship 
Program at Westchester Medical Center quickly found himself in a frontline role treating 
COVID-19 patients.
As this year’s keynote speaker at Touro College’s Annual Research Day, Dr. Dhand shared 
how the medical community harnessed their ever-evolving knowledge of COVID-19 to best 
care for patients. “The amount of learning that we have been able to do in the last year is a big 
win for science and our knowledge has exponentially increased, which has translated to better 
care of our patients,” said Dr. Dhand.
We thank Salomon Amar, D.D.S., Ph.D., vice president for research at NYMC and senior vice president for research affairs for 
Touro College and University System (TCUS) and chair of the TCUS Biomedical and Health Sciences Research Council for 
organizing Touro Research Day. 
Read full story about Dr. Dhand’s address.
Tamar Gomolin Collaborates on Paper on Dangers of Postponing Melanoma 
Diagnosis and Treatment During COVID-19 Pandemic
Last spring, with her clinical rotation in anesthesiology at NYC Health + Hospitals/
Metropolitan (MET) postponed due to the COVID-19 outbreak, Tamar Gomolin, SOM 
Class of 2021, thought a lot about the impact that postponement of medical and surgical 
procedures might have on cancer patient outcomes. The result was a viewpoint paper, 
which Ms. Gomolin collaborated on with Abigail Cline, M.D. Ph.D., dermatology resident, 
and Marc Z. Handler, M.D., adjunct assistant professor of dermatology, that was 
published in the Journal of Dermatological Treatment.  
“When the COVID-19 pandemic hit, I became increasingly concerned for cancer patients 
whose treatment and care would be inadvertently delayed due to COVID-related 
appointment cancellations,” said Ms. Gomolin, who will be continuing on to residency in 
dermatology at MET after graduation. “In addition, some patients may be unaware that 
a skin lesion has progressed and is in fact an emergency. Regardless of the reasons 
for delays in management of pigmented lesions, some out of the provider’s control, the 
consequences of delayed melanoma diagnosis and treatment can be grave.” 
The article addresses the dangers of neglecting melanoma during the COVID-19 pandemic with regard to mortality, morbidity 
and healthcare costs, as well as the importance of prospectively evaluating teledermatology, while continuing to see patients 
with pigmented lesions in person due to the necessity of early surgical intervention. 
“The suspension of clinical rotations during my third year was difficult,” she said. “I missed interacting with patients and 
engaging with an inter-professional team. However, diving into dermatology research brought a tremendous amount of 
meaning and purpose to my time during quarantine. I am enthusiastic about the future and hope I can continue to contribute 
to the exciting field of dermatology.”
New York Health + Hospitals/Metropolitan Holds Resident Research Day
New York Health + Hospitals/Metropolitan (MET) held their annual Resident 
Research Day on May 13, when three residents were selected to present their 
research out of a record-setting 48 abstract submissions. 
Sonja Jauhal, M.D., emergency medicine resident, presented research findings 
from the Healthy East Harlem Initiative, George Ide, M.D., psychiatry resident, 
presented on a comparison of readmission rates of patients admitted to inpatient 
psychiatric units treated with first generation versus second generation long-
acting antipsychotics and internal medicine resident Monil Majmundar, M.D., 
presented on a retrospective cohort study on the absolute lymphocyte count as a 
predictor of mortality and readmission in heart failure hospitalization.
“Despite the challenges this year, it is an indication of the priority and importance of research during residency training that 
this event continues to be held at Metropolitan,” said Richard McCarrick, M.D., M.H.A., vice dean for graduate medical 
education and continuing medical education in the SOM and vice chancellor for college student services at NYMC. “It’s been 
said that research is both a means to an end and an end in itself. There are many barriers to resident participation in research, 
but those we have heard from today and all of the residents who submitted abstracts certainly have an added element of 
commitment discipline, energy, ambition and intellectual curiosity to have completed the projects that they did while they were 
residents—and this is an achievement that we’re all very proud of.”
The relationship between MET and NYMC, which dates back to 1875, is particularly notable as the longest partnership 
between a public hospital and private medical college in the history of the United States. The residency programs at MET are 
also unique in that they are directly sponsored by the NYMC SOM.
“For the past 146 years, our shared faculty, shared residents and our shared students have cared for patients and learned 
medicine together,” said Edward C. Halperin, M.D., chancellor and chief executive officer of NYMC. “At Metropolitan, we have 
a proud history, a great present and an exciting future ahead of us. All of us at the College are pleased to be your partner in 
this journey.”
The event concluded with the awards presentation. Healthy East Harlem Initiative placed first; the retrospective cohort study 
on the absolute lymphocyte count as a predictor of mortality and readmission in heart failure hospitalization placed second; 
and the comparison of readmission rates of patients admitted to inpatient psychiatric units treated with first generation versus 
second generation long-acting antipsychotics placed third. Read full story on Resident Research Day.
Tamar Gomolin
Neurosurgery Summer Research Program Supports Student Research 
Since it began in 2018, the Summer Research and Clinical Neurosurgery 
Program has supported SOM students on more than 60 original clinical 
research projects, review articles and book chapters on neurological topics 
ranging from acute ischemic and hemorrhagic stroke to technological 
updates and COVID-19, which have resulted in numerous publications and 
student accolades.
“Over the course of my career, there have been countless instances during 
which I have found myself seeking the sage counsel, advice or assistance 
of mentors, who have helped guide and shape my career. Consequently, 
teaching medical students, residents and fellows has become a major focus 
of my career,” said Fawaz Al-Mufti, M.D., (top left of the screen) assistant 
professor of neurology, neurosurgery and of radiology, who currently directs the Summer Research Program with Jared 
Pisapia, M.D., assistant professor of neurosurgery. “As part of the program, I have been fortunate to work with and mentor 
more than 35 medical students. It has been an immense honor to assist my mentees reach their potential and play a role 
in their career development. The goal is to educate them on the research process and evolve as a responsible and resilient 
physician-scientist.”
The six-week program, which was developed by Chirag Gandhi, M.D., chair of the Department of Neurosurgery and 
professor of neurosurgery, neurology and of radiology, is open to rising second-year SOM students. The program begins 
with lectures to provide an overview of research study design and scientific writing. Students then pursue a clinical research 
project with the goal of producing a publishable manuscript in the form of an original article, review article or book chapter, 
with regular weekly meetings held with a research mentor to monitor progress. Read full story on Summer Research Program. 
Department of Obstetrics and Gynecology Holds Resident Research Day 
The Department of Obstetrics and Gynecology hosted their annual Resident Research Day on 
April 8, which featured a keynote address on best practices in research collaboration by Kate 
Meriwether, M.D., research committee chair for the Society of Gynecologic Surgeons.
During the event, several residents presented their research on topics in obstetrics and 
gynecology. Following the presentations, Rayna Triestch, M.D., (top right) chief obstetrics and 
gynecology resident, received a first place award for her randomized controlled trial investigating 
whether self-evaluation improves surgical skill. Itamar Futterman, M.D., (lower right) obstetrics 
and gynecology resident, received the second place award for his research on whether patients 
with fetal growth restriction and abnormal umbilical artery dopplers can safely undergo induction 
of labor.
“At this event, we celebrated our resident’s accomplishments of multiple presentations at 
national conferences and publications in peer-reviewed journals,” said Cara I. Grimes, M.D., 
associate professor of obstetrics and gynecology and of urology. “I was so impressed with the 
depth and breadth of their research interests and the effort they put into their investigations. All of 
these residents have already established themselves as excellent clinical researchers and I look 
forward to following their academic successes throughout their careers.”
“This was our 20th Annual Resident Research Day and a special year as our celebration last 
year was postponed due to COVID-19,” said Sean S. Tedjarati, M.D., clinical professor and chair 
of Department of Obstetrics and Gynecology. “However during the pandemic, our residents and 
department were incredibly productive, increasing the number of active protocols 300 percent 
from 2019. Last year, our department had 17 presentations at national meetings and 20 published 
manuscripts. So far in 2021, we have 11 accepted presentations and six publications to date. We 
look forward to further research productivity from our residents and department and to expanding 




Faculty Publications & Updates
NYMC faculty are notable scholars and researchers who are recognized for their accomplishments and published in leading 
journals across a wide range of health science disciplines. This listing represents just a small sample.
Fawaz Al-Mufti, M.D., assistant professor of neurology, neurosurgery and of radiology; Christian Becker, M.D., associate 
professor of anesthesiology and medicine; Hussein Alshammari, M.D., neurology resident; Jared Cooper, M.D., 
neurosurgery resident; Edwin Gulko, M.D., assistant professor of radiology; Gurmeen Kaur, M.D., assistant professor of 
neurology and neurosurgery; Ramandeep Sahni, M.D., clinical associate professor of neurology; Corey Scurlock, M.D., 
M.B.A., clinical professor of anesthesiology and medicine, and Chirag D. Gandhi, M.D., chair of Department of Neurosurgery 
and professor of neurosurgery, neurology and of radiology, published “Acute Cerebrovascular Disorders and Vasculopathies 
Associated with Significant Mortality in SARS-CoV-2 Patients Admitted to The Intensive Care Unit in The New York Epicenter” 
in the Journal of Stroke & Cerebrovascular Diseases. 
Leslie Citrome, M.D., M.P.H., clinical professor of psychiatry and behavioral sciences, published “Olanzapine Plus 
Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial” in 
the Journal of Clinical Psychiatry. 
Abigail Cline, M.D., dermatology resident; Abrahem Kazemi, M.D., dermatology resident; Bijan Safai, M.D., D.S.C., chair 
of Department of Dermatology and professor of dermatology and of pathology, microbiology and immunology; and Shoshana 
Marmon, M.D., Ph.D., clinical assistant professor of dermatology, published “A surge in the incidence of telogen effluvium in 
minority predominant communities heavily impacted by COVID-19” in the Journal of the American Academy of Dermatology. 
Robert Fekete, M.D., associate professor of neurology, published “Impulse Control Disorders in Parkinson’s Disease: 
Epidemiology, Pathogenesis and Therapeutic Strategies” in Frontiers in Psychiatry. 
Cara L. Grimes, M.D., associate professor of obstetrics and gynecology and of urology, published “Female pelvic medicine 
and reconstructive surgery challenges on behalf of the Collaborative Research in Pelvic Surgery Consortium: managing 
complicated cases” in International Urogynecology Journal.
Chengyue Jin, M.D., medicine resident; Daniel Frenkel, M.D., clinical assistant professor of medicine; Jason T. Jacobson, 
M.D., associate professor of medicine; Sei Iwai , M.D., professor of clinical medicine; and Aileen Ferrick, Ph.D., R.N., 
assistant professor of medicine, published “Unique technique to relieve left ventricular assist device electromagnetic 
interference with an implantable cardioverter defibrillator” in the Journal of Cardiovascular Electrophysiology.
David F. Kronn, M.D., associate professor of pediatrics and of pathology, microbiology and immunology, published “Mini-
COMET study: Effects of repeat avalglucosidase alfa dosing on ptosis in participants with infantile-onset Pompe disease 
(IOPD) who were previously treated with alglucosidase alfa” in Molecular Genetics and Metabolism.
Hanjoo Lee, M.D., instructor of surgery; Rifat Latifi, M.D., professor and chair of Department of Surgery; and Roberto 
Bergamaschi, M.D., Ph.D., professor of surgery, published “Delayed urinary bladder perforation in a hostile post-radiation 
pelvis” in Acta Chirurgica Belgica.
Jayaji M. Moré, SOM Class of 2020; Justin A. Miller, SOM Class of 2023; and Mill Etienne, M.D. ’02, M.P.H., vice 
chancellor of diversity and inclusion, associate dean of student affairs and associate professor of neurology and medicine, 
published “Disaster Neurology Update: Focus on the COVID-19 pandemic” in Neurology Clinical Practice.
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